The Federal Trade Commission (FTC) on Friday sued the three largest pharmacy benefit managers (PBMs) for engaging in alleged ...

The FTC says three companies that process about 80% of prescriptions in the United States have engaged in anticompetitive ...

The federal government is suing some big pharmacy benefit managers over a system of drug rebates that regulators say has made ...

Millions of Americans with diabetes need insulin to survive, yet for many of these vulnerable patients, their insulin drug ...

The Federal Trade Commission sued the drug middlemen that health plans use to keep a lid on drug spending, accusing the firms ...

The federal government has initiated a lawsuit against leading Pharmacy Benefit Managers (PBMs) — Caremark, Express Scripts, and OptumRx — accusing them of anticompetitive practices that have driven ...

Cigna may have the edge with smaller footprint and focused approach, but all three giants face risks from FTC's lawsuit over inflated insulin prices.

The Federal Trade Commission on Friday sued prescription-drug middlemen owned by CVS Health Corp., Cigna Group and UnitedHealth Group Inc., alleging that they artificially pumped up prices of insulin ...

The Federal Trade Commission alleges CVS Health’s Caremark Rx, Cigna’s Express Scripts and United Health Group’s OptumRx ...

The agency alleges CVS’s Caremark, Cigna’s Express Scripts and UnitedHealth’s Optum Rx accepted money from drugmakers in ...

Regulators say the nation's largest pharmacy benefit managers are partly to blame for the soaring cost of insulin in the U.S.

The U.S. Federal Trade Commission sued the country's three largest pharmacy benefit managers on Friday, accusing them of ...